journal club- pros of switching from omalizumab or mepolizumab to benralizumab in asthma patients
Published 2 years ago • 597 plays • Length 2:59Download video MP4
Download video MP3
Similar videos
-
10:20
does niv/bipap improve outcomes in asthma exacerbations? journal club-ish (saving lives podcast)
-
0:34
frank albers, md, phd: mepolizumab columba study reports consistent 3-plus year benefits
-
2:16
journal club - probiotics help reduce asthma exacerbations in children
-
24:42
journal club december 2018: dual vs triple inhaler therapy copd
-
1:25
the immulab trial: pembrolizumab with local ablation for patients with early-stage hcc
-
13:32
noacs should replace warfarin in all patients with atrial fibrillation - pro - j. camm
-
14:24
trump's meltdown over new election fraud evidence, melania's abortion stance & gop hypocrisy is real
-
6:42
#1 sign that you overdosed on vitamin d
-
1:17:58
what to expect in an msl interview
-
3:22
osimertinib plus chemotherapy shows superior results versus osimertinib alone for egfr-mutated a...
-
0:37
asthma or copd? let’s clear the air!pulmonologist dr. joann scoon breaks it down.
-
18:05
journal club: manual compression of abdomen to assess expiratory flow limitation
-
5:18
biologic treatment selection in severe asthma: questions & answers
-
5:38
module 4 treatment omalizumab
-
16:32
journal club: a non-invasive method to detect high respiratory effort and dynamic δpl during mv
-
39:51
dupilumab in persistent asthma: pulmonary journal club *
-
2:20
biopharmaceuticals ambition in asthma
-
53:06
vii ifso journal club by dr frits berends
-
1:13
monitoring patients with cll on ibrutinib-based therapies
-
1:56
asthma
-
4:11
clinical updates in the management of severe asthma
-
4:12
substitutes or complements? diagnosis and treatment with non-conventional and conventional medicine